Ongoing Disclosure Notices

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
30-Aug-24
Date on which issuer listed or appointment made:
1-Nov-21
Director or senior manager giving disclosure
Full name:
Julie Dillon
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
CEO Animal Care
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class:8,082
Nature of relevant interest:
Registered holder (issued pursuant
to performance rights plan)
Current registered holder: Julie Dillon
Summary of specified derivatives relevant interest (if applicable)
Type of derivative: N/A
Class of underlying financial products:N/A
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:N/A
Maturity date of the derivative (if any):N/A
Expiry date of the derivative (if any):N/A
The price specified in the terms of the derivative(if any):N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:30-Aug-24
Name and title of authorised person:
Janelle Cain, General Counsel
EBOS Group Limited

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
30-Aug-24
Date of last disclosure:
1-Sep-23
Director or senior manager giving disclosure
Full name(s):
Brett Barons
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
CEO, Symbion
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares
Nature of the affected relevant interest(s):
Issue of shares pursuant to performance
rights plan
For that relevant interest-
Number held in class before acquisition or disposal:
45,777 ordinary shares
Number held in class after acquisition or disposal:
68,069 ordinary shares
Current registered holder(s):
N/A
Registered holder(s) once transfers are registered:
Brett Barons
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:
30-Aug-24
Nature of transaction:
Issue of shares pursuant to performance
rights plan
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
Nil
Number of financial products to which the transaction related: 22,292 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary shares
Nature of relevant interest:
1. Registered holder - 2016 long term
incentive plan
2. Registered holder - 2017 long term
incentive plan
For that relevant interest,-
Number held in class:
1. 55,000 ordinary shares
2. 55,000 ordinary shares
Current registered holder(s):Brett Barons
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
30-Aug-24
Name and title of authorised person:
Janelle Cain, General Counsel, EBOS Group
Limited

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
30-Aug-24
Date of last disclosure:
6-Sep-22
Director or senior manager giving disclosure
Full name(s):
John Cullity
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares
Nature of the affected relevant interest(s):
Issue of shares pursuant to performance
rights plan
For that relevant interest-
Number held in class before acquisition or disposal:
24,186 ordinary shares
Number held in class after acquisition or disposal:
71,248 ordinary shares
Current registered holder(s):
N/A
Registered holder(s) once transfers are registered:
John Cullity
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:
30-Aug-24
Nature of transaction:
Issue of shares pursuant to performance
rights plan
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
Nil
Number of financial products to which the transaction related: 47,062 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Ordinary shares
Nature of relevant interest:
1. Registered holder - 2016 long term
incentive plan
2. Registered holder - 2017 long term
incentive plan
3. Elizabeth Mary Coutts & John Matthew
Cullity as trustees for the EBOS Staff Share
Plan
For that relevant interest,-
Number held in class:
1. 95,000 ordinary shares
2. 110,000 ordinary shares
3. 71,592 ordinary shares
Current registered holder(s):
1&2 John Cullity
3. Elizabeth Mary Coutts & John Matthew
Cullity as trustees for the EBOS Staff Share
Plan
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
30-Aug-24
Name and title of authorised person:
Janelle Cain, General Counsel, EBOS Group
Limited

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
30-Aug-24
Date of last disclosure:
28-Mar-24
Director or senior manager giving disclosure
Full name(s):
Leonard Hansen
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares
Nature of the affected relevant interest(s):
Issue of shares pursuant to
performance rights plan
For that relevant interest-
Number held in class before acquisition or disposal:
14,624
Number held in class after acquisition or disposal:
23,293
Current registered holder(s):
N/A
Registered holder(s) once transfers are registered:
Leonard Hansen
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:30-Aug-24
Nature of transaction:
Issue of shares pursuant to
performance rights plan
Name of any other party or parties to the transaction (if known):N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
Nil
Number of financial products to which the transaction related: 8,669 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
30-Aug-24
Name and title of authorised person:
Janelle Cain, General Counsel,
EBOS Group Limited